Chemotherapy

Less Invasive Surgery Appears Safe in Node+ Breast Cancer

by

TOPLINE: Patients with clinically node-negative breast cancer after neoadjuvant chemotherapy demonstrated low axillary and locoregional recurrence rates after sentinel lymph node biopsy (SLNB) or targeted axillary dissection. METHODOLOGY: More conservative treatment options for women with node-positive breast cancer include SLNB and targeted axillary dissection. However, data comparing patient outcomes after targeted axillary dissection and SLNB … Read more

New treatment identified for peripheral nerve sheath tumors

by

A multicenter collaboration led by the Bellvitge Biomedical Research Institute (IDIBELL) – Institut Català d’Oncologia (ICO) and the Germans Trias i Pujol Research Institute (IGTP) identified a potential new treatment for an aggressive sarcoma arising in the nerves. The findings have been published in the journal Clinical Cancer Research. A rare aggressive tumor arising in the nerves It … Read more

Single dose of novel drug shows tumor-clearing potential in breast cancer models

by

Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women. Treatment typically involves surgery and follow-up hormone therapy, but late effects of these treatments include osteoporosis, sexual dysfunction and blood clots. Now, researchers reporting in ACS Central Science have created a novel treatment that eliminated small breast tumors and significantly … Read more

Insights From the Pre-Immunotherapy Era

by

Patients with multiple myeloma (MM) remain exceptionally vulnerable to infections, which greatly increases mortality risk. Although the advent of novel treatments has brought many benefits to this patient population, individuals with multiple myeloma are 5 times more likely to contract infections, according to a recent population-based study published in Haematologica.1 Infection risk concept; floating viral … Read more

Lack of Chemoradiation Impact in Endometrial Cancer

by

This transcript has been edited for clarity.  Hello. I’m Dr Maurie Markman from City of Hope. I wanted to briefly discuss a very important paper. This is one that probably didn’t get as much attention as I believe it should. It looks at a very important clinically relevant question, and one that might very much … Read more

New test could predict lung cancer outcomes using tumor DNA

by

Scientists from the Francis Crick Institute, UCL, UCLH and Personalis have found that a test to detect circulating tumor DNA can predict lung cancer outcome in a Cancer Research UK-funded study. Circulating tumor DNA (ctDNA) is fragments of DNA released into the blood by tumors. It’s known to be important for disease prognosis but can … Read more

Woman Diagnosed with Terminal Cancer at 25: A Decade of Defying the Odds

by

Archyde Overcoming⁤ the Odds: A Story ‍of Resilience and Hope At just 25 years old, Jyoti⁢ smith received a diagnosis ‌that would ⁢change her⁣ life forever. Terminal cancer. For most, such ​news would feel like ‌a nightmare, but Jyoti chose to face it head-on, defying the odds and inspiring ⁤countless ‌others along the way. “I … Read more